• Grail published a PATHFINDER 2 research presentation on diagnostic evaluations following positive multi-cancer early detection tests.
• Cancer signal origin-guided evaluations identified 88% of cancers; the top two origin predictions were accurate in 91% of cases.
• Diagnostic resolution reached 94.8% among 290 evaluated participants, with a median time of 48 days.
• Invasive procedures occurred in 91% of participants diagnosed with cancer versus 49.6% of those without cancer at 12 months.
• PET-CT following negative targeted evaluations found seven additional cancers among 65 participants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.